Portugal, Sept. 2 -- Portugal based PIERRE FABRE MEDICAMENT PORTUG has secured contract from Instituto Portugues De Oncologia De Coimbra Francisco Gentil, E. P. E. for Np1 Binimetinib 45 Mg. The value of the contract is worth 15614208 EUR.

Published by HT Digital Content Services with permission from Pivotal Sources....